This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Terborg, C. Articles by Röther, J. Search for Related Content PubMed PubMed Citation Articles by Terborg, C. Articles by Röther, J. Related Collections Pathophysiology Brain Circulation and Metabolism Computerized tomography and Magnetic Resonance Imaging Doppler ultrasound, Transcranial Doppler etc.

(Stroke. 2000;31:924.)
© 2000 American Heart Association, Inc.

Original Contributions

Reduced Vasomotor Reactivity in Cerebral Microangiopathy

A Study With Near-Infrared Spectroscopy and Transcranial Doppler Sonography

Christoph Terborg, MD; Felix Gora, MS; Cornelius Weiller, MD Joachim Röther, MD

From the Departments of Neurology, Friedrich-Schiller University of Jena (C.T., F.G., C.W., J.R.) and University Hospital Eppendorf (C.W., J.R.), Hamburg, Germany.

Correspondence to Christoph Terborg, MD, Department of Neurology, Friedrich-Schiller University of Jena, Philosophenweg 3, 07740 Jena, Germany. E-mail Terborg{at}landgraf.med.uni-jena.de

Background and Purpose—Reduction of cerebral blood flow and vasomotor reactivity (VMR) are thought to play an important role in the pathogenesis of cerebral microangiopathy. The aim of our study was to determine whether near-infrared spectroscopy (NIRS) can detect a reduced VMR in patients with microangiopathy, whether NIRS reactivities correlate with VMR assessed by transcranial Doppler sonography (TCD), and whether the differing extents of patients’ microangiopathy demonstrated on MRI or CT can be distinguished by both noninvasive techniques.

Methods—We compared the VMR of 46 patients with cerebral microangiopathy with 13 age-matched control subjects. Patients were classified with the Erkinjuntti scale. We monitored cerebral blood flow velocity (CBFV) in both middle cerebral arteries by TCD, changes in concentration of oxyhemoglobin (HbO₂), deoxyhemoglobin (Hb) and blood volume (HbT) by NIRS, mean arterial blood pressure, and end-tidal CO₂ (EtCO₂) during normocapnia and hypercapnia. VMRs were calculated as percent change of CBFV (NCR) and as absolute change in concentration of HbO₂, Hb, and HbT per 1% increase in EtCO₂ (CR-HbO₂, CR-Hb, CR-HbT).

Results—NCR and NIRS reactivities were significantly reduced in patients with cerebral microangiopathy. CR-HbO₂ and CR-Hb showed a close correlation with NCR, and NCR and NIRS reactivities were related to the severity of cerebral microangiopathy according to the Erkinjuntti scale. Validity of NCR and NIRS reactivities were similar.

Conclusions—VMR is reduced in patients with cerebral microangiopathy and can be noninvasively assessed in basal arteries (with TCD) and brain parenchyma (with NIRS). Reduction of CO₂-induced VMR, as measured by NIRS and TCD, may indicate the severity of microangiopathy.

Key Words: cerebral blood flow • microangiopathy • spectroscopy, near-infrared • ultrasonography, Doppler, transcranial • vasomotor reactivity

This article has been cited by other articles:

				E. Nur, Y.-S. Kim, J. Truijen, E. J. van Beers, S. C. A. T. Davis, D. P. Brandjes, B. J. Biemond, and J. J. van Lieshout Cerebrovascular reserve capacity is impaired in patients with sickle cell disease Blood, October 15, 2009; 114(16): 3473 - 3478. [Abstract] [Full Text] [PDF]

				G. M. Kozera, B. Wolnik, K. B. Kunicka, S. Szczyrba, J. Wojczal, U. Schminke, W. M. Nyka, and L. Bieniaszewski Cerebrovascular Reactivity, Intima-Media Thickness, and Nephropathy Presence in Patients With Type 1 Diabetes Diabetes Care, May 1, 2009; 32(5): 878 - 882. [Abstract] [Full Text] [PDF]

				P. C. Lavallee, J. Labreuche, F. Gongora-Rivera, A. Jaramillo, D. Brenner, I. F Klein, P.-J. Touboul, E. Vicaut, P. Amarenco, and on behalf of the Lacunar-B.I.C.H.A.T. Investigator Placebo-Controlled Trial of High-Dose Atorvastatin in Patients With Severe Cerebral Small Vessel Disease Stroke, May 1, 2009; 40(5): 1721 - 1728. [Abstract] [Full Text] [PDF]

				B. W. Carlson, V. J. Neelon, J. R. Carlson, M. Hartman, and S. Dogra Cerebrovascular Disease and Patterns of Cerebral Oxygenation During Sleep in Elders Biol Res Nurs, April 1, 2009; 10(4): 307 - 317. [Abstract] [PDF]

				H. S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol, January 1, 2008; 93(1): 121 - 127. [Abstract] [Full Text] [PDF]

				K.-J. Bar, M. K. Boettger, N. Seidler, H. J. Mentzel, C. Terborg, and H. Sauer Influence of Galantamine on Vasomotor Reactivity in Alzheimer's Disease and Vascular Dementia Due to Cerebral Microangiopathy Stroke, December 1, 2007; 38(12): 3186 - 3192. [Abstract] [Full Text] [PDF]

				U. Khan, L. Porteous, A. Hassan, and H. S Markus Risk factor profile of cerebral small vessel disease and its subtypes J. Neurol. Neurosurg. Psychiatry, July 1, 2007; 78(7): 702 - 706. [Abstract] [Full Text] [PDF]

				J. Birns, H. Markus, and L. Kalra Blood Pressure Reduction for Vascular Risk: Is There a Price To Be Paid? Stroke, June 1, 2005; 36(6): 1308 - 1313. [Abstract] [Full Text] [PDF]

				K. Yoshitani, M. Kawaguchi, M. Iwata, N. Sasaoka, S. Inoue, N. Kurumatani, and H. Furuya Comparison of changes in jugular venous bulb oxygen saturation and cerebral oxygen saturation during variations of haemoglobin concentration under propofol and sevoflurane anaesthesia Br. J. Anaesth., March 1, 2005; 94(3): 341 - 346. [Abstract] [Full Text] [PDF]

				M. Walters, S. Muir, I. Shah, and K. Lees Effect of Perindopril on Cerebral Vasomotor Reactivity in Patients With Lacunar Infarction Stroke, August 1, 2004; 35(8): 1899 - 1902. [Abstract] [Full Text] [PDF]

				A. Hassan, B. J. Hunt, M. O'Sullivan, R. Bell, R. D'Souza, S. Jeffery, J. M. Bamford, and H. S. Markus Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction Brain, January 1, 2004; 127(1): 212 - 219. [Abstract] [Full Text] [PDF]

				C. Zimmermann and R.L. Haberl L-Arginine Improves Diminished Cerebral CO2 Reactivity in Patients Stroke, March 1, 2003; 34(3): 643 - 647. [Abstract] [Full Text] [PDF]

				A. Hassan, B. J. Hunt, M. O'Sullivan, K. Parmar, J. M. Bamford, D. Briley, M. M. Brown, D. J. Thomas, and H. S. Markus Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis Brain, February 1, 2003; 126(2): 424 - 432. [Abstract] [Full Text] [PDF]

				H Tiemeier, S L M Bakker, A Hofman, P J Koudstaal, and M M B Breteler Cerebral haemodynamics and depression in the elderly J. Neurol. Neurosurg. Psychiatry, July 1, 2002; 73(1): 34 - 39. [Abstract] [Full Text] [PDF]

				K. Yoshitani, M. Kawaguchi, K. Tatsumi, K. Kitaguchi, and H. Furuya A Comparison of the INVOS 4100 and the NIRO 300 Near-Infrared Spectrophotometers Anesth. Analg., March 1, 2002; 94(3): 586 - 590. [Abstract] [Full Text] [PDF]

				P. Sterzer, F. Meintzschel, A. Rosler, H. Lanfermann, H. Steinmetz, and M. Sitzer Pravastatin Improves Cerebral Vasomotor Reactivity in Patients With Subcortical Small-Vessel Disease Stroke, December 1, 2001; 32(12): 2817 - 2820. [Abstract] [Full Text] [PDF]